IRF
BIO icon

IBM Retirement Fund’s Bio-Rad Laboratories Class A BIO Stock Holding History

IBM Retirement Fund’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-353
Closed -$267K – 511
2021
Q4 		$267K Sell
353
-242
-41% -$181K 0.03% 463
2021
Q3 		$444K Hold
595
– – 0.03% 450
2021
Q2 		$383K Sell
595
-122
-17% -$74.3K 0.03% 509
2021
Q1 		$410K Sell
717
-63
-8% -$37.3K 0.03% 508
2020
Q4 		$455K Buy
780
+95
+14% +$54.1K 0.03% 482
2020
Q3 		$353K Buy
685
+192
+39% +$97.2K 0.03% 473
2020
Q2 		$223K Buy
+493
New +$218K 0.03% 490
2017
Q1 		– Sell
-1,672
Closed -$305K – 396
2016
Q4 		$305K Sell
1,672
-308
-16% -$52.5K 0.01% 769
2016
Q3 		$324K Sell
1,980
-116
-6% -$17.6K 0.02% 803
2016
Q2 		$300K Sell
2,096
-3
-0.1% -$428 0.01% 849
2016
Q1 		$287K Sell
2,099
-2,675
-56% -$351K 0.01% 858
2015
Q4 		$662K Buy
+4,774
New +$662K 0.01% 904
2015
Q3 		– Sell
-4,796
Closed -$722K – 941
2015
Q2 		$722K Sell
4,796
-112
-2% -$16K 0.01% 885
2015
Q1 		$663K Sell
4,908
-17
-0.3% -$2.11K 0.01% 897
2014
Q4 		$594K Buy
4,925
+468
+11% +$53.9K 0.01% 924
2014
Q3 		$505K Sell
4,457
-585
-12% -$69.3K 0.01% 940
2014
Q2 		$608K Sell
5,042
-41
-0.8% -$5.01K 0.01% 947
2014
Q1 		$658K Sell
5,083
-2,896
-36% -$371K 0.01% 898
2013
Q4 		$987K Sell
7,979
-114
-1% -$13.9K 0.01% 906
2013
Q3 		$951K Sell
8,093
-1,375
-15% -$162K 0.01% 906
2013
Q2 		$1.06M Buy
+9,468
New +$1.11M 0.01% 895

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IBM Retirement Fund's BIO Position: Q1 2022 in Review

IBM Retirement Fund sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 353 shares — an estimated $267K sold.

IBM Retirement Fund first reported a position in BIO in Q2 2013 and held it in 21 quarters. The position peaked at $1.06M in Q2 2013. 514 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

  • IBM Retirement Fund reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 353 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $267K.
  • IBM Retirement Fund first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 21 quarters.
  • IBM Retirement Fund's Bio-Rad Laboratories Class A position peaked at $1.06M in Q2 2013.
  • 514 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on IBM Retirement Fund's 13F filing for Q1 2022, filed 14 Apr 2022.